Covered recipient · General Payments record
RACHEL MELISSA CYMERMAN
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2021–2024
$1,690.80
- Reported across 55 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $749.01 | 27 |
| Education | $179.98 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $195.61 | 4 |
| Janssen Biotech, Inc. | $181.42 | 4 |
| ABBVIE INC. | $170.11 | 7 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $135.14 | 3 |
| PFIZER INC. | $88.16 | 4 |
| Incyte Corporation | $83.46 | 4 |
| LEO Pharma Inc. | $48.84 | 2 |
| GENZYME CORPORATION | $26.25 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $29.18 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103524774 | CMS |
| ABBVIE INC. | $28.91 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103524776 | CMS |
| ABBVIE INC. | $24.58 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103524778 | CMS |
| ABBVIE INC. | $1.56 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103524780 | CMS |
| ABBVIE INC. | $27.86 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103524782 | CMS |
| ABBVIE INC. | $27.69 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103524784 | CMS |
| ABBVIE INC. | $30.33 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103524786 | CMS |
| GENZYME CORPORATION | $26.25 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139888294 | CMS |
| Incyte Corporation | $19.36 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141224100 | CMS |
| Incyte Corporation | $27.74 | 07/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141225502 | CMS |
| Incyte Corporation | $14.25 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141226762 | CMS |
| Incyte Corporation | $22.11 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141302707 | CMS |
| Janssen Biotech, Inc. | $28.70 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078434025 | CMS |
| Janssen Biotech, Inc. | $25.00 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078434038 | CMS |
| Janssen Biotech, Inc. | $99.99 | 07/30/2024 | Education | Undisputed | 01/23/2026 | 1078434030 | CMS |
| Janssen Biotech, Inc. | $27.73 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078434034 | CMS |
| LEO Pharma Inc. | $22.94 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152625171 | CMS |
| LEO Pharma Inc. | $25.90 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152625173 | CMS |
| Lilly USA, LLC | $120.23 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135200061 | CMS |
| Lilly USA, LLC | $18.39 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135307475 | CMS |
| Lilly USA, LLC | $26.53 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135300631 | CMS |
| Lilly USA, LLC | $30.46 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135329914 | CMS |
| PFIZER INC. | $21.10 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131508057 | CMS |
| PFIZER INC. | $22.88 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131743502 | CMS |
| PFIZER INC. | $21.32 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131844997 | CMS |
| PFIZER INC. | $22.86 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131133705 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $27.14 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152192572 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $79.99 | 08/27/2024 | Education | Undisputed | 01/23/2026 | 1152192570 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $28.01 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152192574 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.